Search filters

List of works by Geoffrey Ku

Adjuvant (postoperative) therapy for esophageal cancer.

scientific article

Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus

scientific article published on May 1, 2012

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

scholarly article

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer

scientific article published on 23 July 2019

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

scientific article

EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

scientific article published on 21 November 2018

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer

scientific article published on 05 April 2019

Erratum: Correlationof clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.

scientific article

Esophagogastric cancer: targeted agents.

scientific article published on February 2010

Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield

scientific article published on 24 September 2015

Long-Term Survival With Salvage Surgery for Recurrent Esophageal Adenocarcinoma After Chemoradiotherapy.

scientific article

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.

scientific article

Management of gastric cancer

scientific article published on 01 November 2014

Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses

scientific article published on January 2009

Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.

scientific article published on 11 October 2011

Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.

scientific article published in May 2009

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer

scientific article published on 14 August 2015

Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer

scientific article published on 01 April 2014

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer

scientific article published on 13 February 2008

Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial

scientific article

Preoperative therapy for esophageal cancer

scientific article published on 01 March 2009

Preoperative therapy in esophageal cancer.

scientific article published on May 2008

Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers

scientific article

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

scientific article published on 01 November 2019

Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma

scientific article

Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma

scientific article published on 11 August 2015

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival

scientific article

Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy.

scientific article published in March 2009

Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan

scientific article published on 01 May 2007